Session Information
-
WCLC 2018
19th World Conference on Lung Cancer
Conference Program for the 19th World Conference on Lung Cancer in Toronto, Canada
Download PDF of the Abstract Book: Click Here.
Presentation Date(s):- Sept 23 - 26, 2018
- Total Presentations: 2391
September 23 Sun
Sep 23 Monday
September 24 Mon
Sep 24 Tuesday
September 25 Tue
Sep 25 Wednesday
September 26 Wed
Sep 26
-
+
P1.01 - Advanced NSCLC (Not CME Accredited Session)
- 16:45 - 18:00
- 9/24/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P1.01-67 - Clinical Relevance of ALK/ROS1 Resistance Mutations and Other Acquired Mutations Detected by Liquid Biopsy in Advanced NSCLC Patients
16:45 - 18:00 | Presenter: Laura Mezquita | Author(s): Aurélie Swalduz, Cecile Jovelet, Sandra Ortiz-Cuaran, David Planchard, Virginie Avrillon, Gonzalo Recondo, Solène Marteau, Vincent Plagnol, Karen Howarth, Clive Morris, Emma Green, Ludovic Lacroix, Luc Odier, Etienne Rouleau, Pierre Fournel, Caroline Caramella, Claire Tissot, Julien Adam, Maurice Pérol, Luc Friboulet, Pierre Saintigny, Benjamin Besse
- Abstract
Loading...
-
+
P1.04 - Immunooncology (Not CME Accredited Session)
- 16:45 - 18:00
- 9/24/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P1.04-31 - Efficacy and Tolerance of Immune-Checkpoint Inhibitors in EGFR, ALK/ROS 1 Non-Small-Cell-Lung-Cancer (NSCLC): GFPC 03-2016 IMAD Study
16:45 - 18:00 | Presenter: Olivier Bylicki | Author(s): Florian Guisier, Isabelle Monnet, Helene Doubre, Radj Gervais, Henri Janicot, Maurice Pérol, Pierre Fournel, Jacques Le Treut, Regine Lamy, Sabine Vieillot, Herve Le Caer, Jean-Bernard Auliac, Christos Chouaid
- Abstract
Loading...
-
+
P1.13 - Targeted Therapy (Not CME Accredited Session)
- 16:45 - 18:00
- 9/24/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P1.13-09 - Efficacy and Tolerance of Osimertinib in Real Word Setting: Results of the French Early Access Program (EXPLORE T790M GFPC Study).
16:45 - 18:00 | Presenter: Jean Bernard Auliac | Author(s): Maurice Pérol, David Planchard, Isabelle Monnet, marie Wislez, Helene Doubre, Florian Guisier, eric Pichon, Laurent Greillier, bennedicte Mastroianni, chantal Decroissette, roland Schott, Sylvestre le Moulec, jennifer Arrondeau, Alexis B Cortot, laurence Gerinière, Aldo Renault, catherine Daniel, lionel Falchero, Christos Chouaid
- Abstract
Loading...
-
+
PC05 - Optimizing Clinical Trial Design in NSCLC
- 10:30 - 12:00
- 9/25/2018
- Location: Room 205 AC
- Type: Pro-Con Session
- Track: Advanced NSCLC
-
+
PC05.04 - Debate 2: Patient Reported Outcomes Should Be the Most Important Endpoint in Trials in the Palliative Setting - YES
11:10 - 11:25 | Presenter: Maurice Pérol
- Abstract
No abstract available for this presentation
-
+
MA16 - Novel Mechanisms for Molecular Profiling
- 13:30 - 15:00
- 9/25/2018
- Location: Room 203 BD
- Type: Mini Oral Abstract Session
- Track: Advanced NSCLC
-
+
MA16.09 - Feasibility, Clinical Relevance of ALK/ROS1 Fusion Variant Detection by Liquid Biopsy in Advanced Non-Small Cell Lung Cancer
14:30 - 14:35 | Presenter: Aurélie Swalduz | Author(s): Laura Mezquita, Sandra Ortiz-Cuaran, Cecile Jovelet, Virginie Avrillon, David Planchard, Solène Marteau, Gonzalo Recondo, Séverine Martinez, Karen Howarth, Vincent Plagnol, Clive Morris, Emma Green, Luc Odier, Ludovic Lacroix, Stéphane Hominal, Etienne Rouleau, Claire Tissot, Caroline Caramella, Pierre Fournel, Luc Friboulet, Maurice Pérol, Benjamin Besse, Pierre Saintigny
- Abstract
Loading...
-
+
OA12 - Novel Therapies in MET, RET and BRAF
- 15:15 - 16:45
- 9/25/2018
- Location: Room 106
- Type: Oral Abstract Session
- Track: Targeted Therapy
-
+
OA12.03 - Activity of Crizotinib in MET or ROS1 Positive (+) NSCLC: Results of the AcSé Trial.
15:35 - 15:45 | Presenter: Denis Moro-Sibilot | Author(s): Nathalie Cozic, Maurice Pérol, Josiane Otto, Julien Mazieres, Pierre-Jean Souquet, Rastislav Bahleda, Marie Wislez, Sophie De Guibert, Bertrand Mennecier, Christos Chouaid, Renaud Sabatier, Suzanna Bota, Radj Gervais, Véronique Verriele, Véronique Haddad, Gilbert Ferretti, Frédérique Nowak, Céline Mahier - Ait Oukhatar, Gilles Vassal
- Abstract
Loading...
-
+
P2.13 - Targeted Therapy (Not CME Accredited Session)
- 16:45 - 18:00
- 9/25/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P2.13-45 - SHERLOC: A Phase 2 Study of Seribantumab in Combination with Docetaxel in Patients with Heregulin Positive, Advanced NSCLC
16:45 - 18:00 | Presenter: Lecia Sequist | Author(s): Pasi A Jänne, Frances A Shepherd, Rudolf M Huber, Jhanelle Elaine Gray, Enriqueta Felip, Maurice Pérol, Fred R. Hirsch, Daniel S.W. Tan, Kim Caliri, Sara Ghassemifar, Ben Wang, Walid Kamoun, Sergio Santillana, Vasileios Askoxylakis, J Marc Pipas
- Abstract
Loading...